Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Investor Alert: Deadline in Lawsuit on May 26, 2025

A deadline is coming up on May 26, 2025 in the lawsuit filed for certain investors of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) over alleged securities laws violations by Actinium Pharmaceuticals, Inc.

Investors who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) have certain options and there are strict and short deadlines running. Deadline: May 26, 2025. Actinium Pharmaceuticals, Inc. (NYSE: ATNM) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) common shares between October 31, 2022, and August 2, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between October 31, 2022, and August 2, 2024, the Defendants failed to disclose that the Company's data from the Sierra Trial was unlikely to satisfy the FDA's guidelines for the acceptance and approval of Iomab-B BLA, that the additional analyses, including long-term follow-ups that purportedly demonstrated a trend towards improved Overall Survival that the Company provided to the FDA in an attempt to mitigate Sierra's poor OS data were unlikely to satisfy the FDA's guidelines for the acceptance and approval of Iomab-B BLA, that as a result, the FDA would likely refuse to review the Iomab-B BLA or, if it did consider that BLA, that the application in its current form was unlikely to be approved, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.